Monday, April 19, 2010
FDA considers halting Avandia safety study; taking the drug off the market next?
Back in February I reported that an FDA report concluded that diabetes prescription drug Avandia should be withdrawn from the market because it was allegedly causing many users to suffer heart attacks. See here. Since then many other stories, reports and studies have been published and debated. See my posts on this here, here, here, here, here, here, here, here, here, here, here and here. Today, The Wall Street Journal reports that the FDA is considering whether to stop a diabetes drug safety study involving patients taking Avandia due to concerns over heart risks and Pharmalot adds that halting the study could also determine whether the drug stays on the market. For more on the story go to AboutLawsuits.com.